Guorui Cao

Dr. Guorui Cao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in International Journal of Surgery
Verified
Journal Article
Closed access
YTYanfeng Tang
Yanfeng Tang
YWYangyang Wen
Yangyang Wen
WLWuyin Li
Wuyin Li
HLHongjun Li
Hongjun Li
YYYuxia Yang
Yuxia Yang
GCGuorui Cao
Guorui Cao
The aim of the study was to identify the efficacy and safety of multiple doses of oral tranexamic acid (TXA) on reducing blood loss and minimizing the postoperative inflammatory and fibrinolytic responses following primary total knee arthroplasty (TKA). In this prospective, double-blinded, randomized trial, we randomly assigned a total of 151 patients into three groups to receive 2 g of oral TXA 2 h preoperatively (group A); an additional dose of 2 g of oral TXA 4 h postoperatively (group B); or additional doses of 2 g of oral TXA at 4, 10, and 16 h postoperatively (group C). The primary outcome was total blood loss (TBL). The secondary outcomes were maximum drop in hemoglobin (Hb) and hematocrit (Hct), level of inflammatory and fibrinolytic parameters, transfusion rate, and the incidence of complications. The results were represented as mean ± standard deviation. The mean TBL was 607 ± 254 mL in group C, 743 ± 347 mL in group B (p = 0.027 vs group C), and 978 ± 335 mL in group A (p 0.05). Multiple postoperative doses of oral TXA could further reduced blood loss and the drop in Hb and Hct, and diminished the postoperative inflammatory and fibrinolytic responses in primary TKA with no apparent increase in the incidence of complications. Level Ⅰ, therapeutic study.

26 September 2021 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
GCGuorui Cao
Guorui Cao
GCGuorui Cao
Guorui Cao
HXHong Xu
Hong Xu
CYChen Yue
Chen Yue
ZeYu HuangZeYu Huang
ZeYu Huang
FPfuxing pei
fuxing pei
Background: Postoperative moderate and severe anemia (PMSA) has been a serious perioperative complication in primary total knee arthroplasty (TKA). However, the ideal cutoff values to predict PMSA is still undetermined. The aim of this study was (1) to identify the risk factors associated with PMSA and (2) to establish the cutoff values of preoperative hemoglobin (HB) associated with increased PMSA in primary TKA. Methods: We identified 474 patients undergoing primary TKA and separated those in which PMSA (HB was less than 110 g/L on postoperative day 1 and 3) was developed from those without PMSA. Multivariate logistic regression model was used to identify independent risk factors for PMSA. Area under the receiver-operator curve (AUC) was used to determine the best-supported preoperative HB cutoff across all the patients. Results: The PMSA rate in primary TKA was 53.2%. Significant risk factors were lower preoperative HB (OR [odds ratio] = 1.138, 95% CI [confidence interval] = 1.107–1.170, p < 0.001) and more intraoperative blood loss (OR = 1.022, 95% CI 1.484–4.598, p < 0.001). A preoperative HB cutoff value that maximized the AUC was 138.5 g/L for men (sensitivity: 79.4%, specificity: 75.0%) and 131.5 g/L for women (sensitivity: 74.7%, specificity: 80.5%), respectively. Conclusion: We should recognize and consider the related risk factors to establish specific, personalized risk assessment for PMSA, including preoperative HB and intraoperative blood loss. Of these, preoperative HB was a referable tool to predict PMSA in primary TKA.

20 December 2021 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
GCGuorui Cao
Guorui Cao
SXShiqi Xiang
Shiqi Xiang
MYMinglu Yang
Minglu Yang
SQSongtao Quan
Songtao Quan
JYJunna Yao
Junna Yao
FPfuxing pei
fuxing pei
Background: Characterizing the impacts of postoperative opioid use on total knee arthroplasty (TKA) patients may help optimize the pain management after TKA. The aim of the study is to examine the prevalence and risk factors for opioid use with an enhanced-recovery programme after primary TKA. Methods: We identified 361 patients undergoing TKA, and separated those on the basis of whether to receive opioid use after surgery. Themultivariate logistic regression model was used to identify independent risk factors for opioid use after primary TKA. Length of stay (LOS) and postoperative complications were also recorded and compared. Results: The prevalence of opioid use after primary TKA was 23.0%. The significant risk factor was the longer operative time (OR [odds ratio] = 1.017, 95% CI [confidence interval] = 1.001 to 1.032, p = 0.034) and the protective factor was the utilization of tranexamic acid(OR= 0.355, 95% CI = 0.161 to 0.780, p = 0.010). In addition, the LOS was longer in opioid group (p < 0.05). Conclusion: Considering the adverse health effects of opioid use, strategies need to be developed to prevent persistent opioid use after TKA. Reducing operative time and the application of tranexamic acid could lower the risk of opioid use with an enhanced-recovery programme after primary TKA.



18 March 2025 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
YLYuanping Liao
Yuanping Liao
XWXiao Wang
Xiao Wang
XSXiaotao Shi
Xiaotao Shi
GCGuorui Cao
Guorui Cao
HTHonglue Tan
Honglue Tan
Patients who undergo reconstruction for multiligament knee injuries (MLKIs) often exhibit knee instability and poor overall knee function during postoperative follow-up. This may be related to the changes in patellar position and decline in patellofemoral function after surgery. To evaluate the outcomes following reconstruction of MLKIs through the assessment of: (1) changes in patellar height; (2) anatomical changes in patellofemoral alignment, such as tilt or displacement; and (3) functional outcomes of the patellofemoral joint. This retrospective study included 45 patients who underwent reconstruction for MLKIs at our hospital between November 2015 and September 2022, with complete data and meeting the inclusion criteria. These patients formed the case group. An additional 20 outpatients without ligament injuries or patellar dislocation were selected as the normal control group. Patellar height changes in the case group were assessed preoperatively and postoperatively using the Caton-Deschamps (CD) and Insall-Salvati (IS) indices on lateral X-rays. Magnetic resonance imaging (MRI) was used to measure patellofemoral alignment parameters in both groups, including the sulcus angle (SA), patellar tilt angle (PTA), lateral patellofemoral angle (LPA), congruence angle (CA), and patellofemoral index (PI), to evaluate patellofemoral positioning. Additionally, the Kujala score questionnaire was used to assess the stability function of the patellofemoral joint. Preoperative patellar height in the case group, measured by the CD and IS indices, was (1.07 ± 0.10, 1.10 ± 0.09), showing a statistically significant difference when compared to postoperative measurements (0.96 ± 0.13, 1.05 ± 0.10) (P < 0.05). However, postoperative patellofemoral alignment parameters, including SA, PTA, LPA, CA, and PI, in the case group showed no statistically significant differences compared to the control group (P > 0.05). At the latest follow-up, the patellofemoral function score in the case group was (89.0 ± 5.3), which was not significantly different from the control group (91.0 ± 2.9) (P > 0.05). After reconstruction of MLKIs, patellar height decreased but remained within the normal range. Patellofemoral alignment was well-maintained, and patellofemoral function was maintained.